Author Correction: SARS-CoV-2 receptor binding domain radio-probe: a noninvasive approach for angiotensin-converting

Dan Li1, Jin Ding1, Te-Li Liu1

  • 1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, 100142, China.

Abstract

No abstract available in PubMed .

Related Concept Videos